Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-10

FDA Approved: TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Trigen Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for tramadol hydrochloride extended-release sponsored by Trigen Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE (tramadol hydrochloride)

Snippet

SUPPL AP for TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE (TRAMADOL HYDROCHLORIDE)